Verapamil Hydrochloride

ANDA 71424, held by Chartwell Rx. Verapamil Hydrochloride.

As of Nov 15, 2026, ANDA 71424 (Verapamil Hydrochloride), held by Chartwell Rx, was first approved by FDA on May 25, 1988, with 11 approved supplements and 0 published complete response letters.

First approved: May 25, 1988
Supplements approved: 11
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 12 submissions below

Date	Submission	Status	Documents
May 25, 1988	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Verapamil Hydrochloride120MG · tablet;oral	Verapamil Hydrochloride	Discontinued

All 12 submissions, including labeling and manufacturing supplements


Dec 16, 2002	Supplement 12Manufacturing	Approved	None posted
Dec 28, 2001	Supplement 11Manufacturing	Approved	None posted
May 5, 1999	Supplement 10Manufacturing	Approved	None posted
Jun 23, 1998	Supplement 9Labeling	Approved	None posted
Mar 30, 1995	Supplement 8Manufacturing	Approved	None posted
Aug 6, 1992	Supplement 7Labeling	Approved	None posted
May 28, 1992	Supplement 6Labeling	Approved	None posted
Apr 22, 1991	Supplement 5Labeling	Approved	None posted
Feb 5, 1991	Supplement 4Manufacturing	Approved	None posted
Feb 5, 1991	Supplement 3Manufacturing	Approved	None posted
Aug 3, 1990	Supplement 1Labeling	Approved	None posted
May 25, 1988	Original application	Approved	None posted

Identifiers

Application: ANDA 71424
Drugs@FDA: Overview at FDA
Company: Chartwell RX

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters